MICA and breast cancer: Another study showed that MICA expression was significantly increased as downstream targets of the MALAT1/p53/miR-155/miR-146a circuit affected by methoxylated quercetin glycoside (MQG), which alters the immunogenic and oncogenic profiles of BC [68].